Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1975 1
1979 2
1981 1
1982 1
1983 2
1985 2
1986 5
1987 8
1988 11
1989 14
1990 11
1991 21
1992 16
1993 15
1994 19
1995 16
1996 12
1997 18
1998 16
1999 26
2000 33
2001 37
2002 39
2003 47
2004 83
2005 82
2006 94
2007 141
2008 167
2009 206
2010 206
2011 222
2012 194
2013 278
2014 356
2015 401
2016 397
2017 463
2018 505
2019 586
2020 653
2021 700
2022 739
2023 348

Text availability

Article attribute

Article type

Publication date

Search Results

6,431 results

Results by year

Filters applied: . Clear all
Page 1
LilrB3 is a putative cell surface receptor of APOE4.
Zhou J, Wang Y, Huang G, Yang M, Zhu Y, Jin C, Jing D, Ji K, Shi Y. Zhou J, et al. Among authors: jin c. Cell Res. 2023 Feb;33(2):116-130. doi: 10.1038/s41422-022-00759-y. Epub 2023 Jan 2. Cell Res. 2023. PMID: 36588123
Rezvilutamide versus bicalutamide in combination with androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer (CHART): a randomised, open-label, phase 3 trial.
Gu W, Han W, Luo H, Zhou F, He D, Ma L, Guo H, Liang C, Chong T, Jiang J, Chen Z, Wang Y, Zou Q, Tian Y, Xiao J, Huang J, Zhu S, Dong Q, Zhang X, Li H, Yang X, Chen C, Li J, Jin C, Zhang X, Ye D; CHART Investigators. Gu W, et al. Among authors: jin c. Lancet Oncol. 2022 Oct;23(10):1249-1260. doi: 10.1016/S1470-2045(22)00507-1. Epub 2022 Sep 5. Lancet Oncol. 2022. PMID: 36075260 Clinical Trial.
Reproducing extracellular matrix adverse remodelling of non-ST myocardial infarction in a large animal model.
Contessotto P, Spelat R, Ferro F, Vysockas V, Krivickienė A, Jin C, Chantepie S, Chinello C, Pauza AG, Valente C, Rackauskas M, Casara A, Zigmantaitė V, Magni F, Papy-Garcia D, Karlsson NG, Ereminienė E, Pandit A, Da Costa M. Contessotto P, et al. Among authors: jin c. Nat Commun. 2023 Feb 22;14(1):995. doi: 10.1038/s41467-023-36350-1. Nat Commun. 2023. PMID: 36813782 Free PMC article.
Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor-naïve patients with myelofibrosis: Results of a phase II trial.
Zhang Y, Zhou H, Jiang Z, Wu D, Zhuang J, Li W, Jiang Q, Wang X, Huang J, Zhu H, Yang L, Du X, Li F, Xia R, Zhang F, Hu J, Li Y, Hu Y, Liu J, Jin C, Sun K, Zhou Z, Wu L, Yu W, Jin J. Zhang Y, et al. Among authors: jin c. Am J Hematol. 2022 Dec;97(12):1510-1519. doi: 10.1002/ajh.26709. Epub 2022 Oct 4. Am J Hematol. 2022. PMID: 36054786 Free PMC article. Clinical Trial.
6,431 results